文献速递胸部肿瘤

肺腺癌中DNA修复基因的胚系突变

Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.
PubMed 文献 · J Thorac Oncol · 2017-08-24

研究利用癌症基因组图谱项目中555例肺腺癌病例的胚系序列数据,检测8个候选基因的胚系突变。在5个基因中检出14个致病突变,频率为2.5%,OR为66(95%CI 33-125,P<0.0001)。结论认为至少2.5%至4.5%的肺腺癌患者携带与孟德尔综合征癌症风险相关的胚系变异,多涉及DNA修复通路。

要点

  • 555例肺腺癌中检出14个致病胚系突变,频率2.5%,OR为66(95%CI 33-125,P<0.0001)。
  • 突变最常见于ATM(50%),其次为TP53、BRCA2、EGFR和PARK2。
  • 86%的变异已在其他家族性癌症综合征中报道,另2%病例携带预测有害的超罕见变异。

核心结论

  • 至少2.5%至4.5%的肺腺癌患者携带与孟德尔综合征癌症风险相关的胚系变异,基因多位于DNA修复通路。
  • 肺腺癌与其他实体瘤类似,包含一部分具有遗传易感性的患者。

研究设计与样本

  • 研究利用癌症基因组图谱项目中已生成但此前未分析的胚系序列数据,纳入555例肺腺癌病例。
  • 基于既往个案关联或全基因组关联研究,选择ATM、BRCA2、CHEK2、EGFR、PARK2、TERT、TP53和YAP1共8个候选基因进行系统检测。

主要发现

  • 在555例肺腺癌病例中检出5个基因的14个致病突变,频率为2.5%,OR为66(95%CI 33-125,P<0.0001,卡方检验)。
  • 突变最常见于ATM(50%),其次为TP53、BRCA2、EGFR和PARK2。
  • 86%的变异已在其他家族性癌症综合征中报道。
  • 另12例(2%)携带被三种蛋白预测程序预测为有害的超罕见变异,最常涉及ATM和BRCA2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Although lung cancer is generally thought to be environmentally provoked, anecdotal familial clustering has been reported, suggesting that there may be genetic susceptibility factors. We systematically tested whether germline mutations in eight candidate genes may be risk factors for lung adenocarcinoma. METHODS: We studied lung adenocarcinoma cases for which germline sequence data had been generated as part of The Cancer Genome Atlas project but had not been previously analyzed. We selected eight genes, ATM serine/threonine kinase gene (ATM), BRCA2, DNA repair associated gene (BRCA2), checkpoint kinase 2 gene (CHEK2), EGFR, parkin RBR E3 ubiquitin protein ligase gene (PARK2), telomerase reverse transcriptase gene (TERT), tumor protein p53 gene (TP53), and Yes associated protein 1 gene (YAP1), on the basis of prior anecdotal association with lung cancer or genome-wide association studies. RESULTS: Among 555 lung adenocarcinoma cases, we detected 14 pathogenic mutations in five genes; they occurred at a frequency of 2.5% and represented an OR of 66 (95% confidence interval: 33-125, p < 0.0001 [chi-square test]). The mutations fell most commonly in ATM (50%), followed by TP53, BRCA2, EGFR, and PARK2. Most (86%) of these variants had been reported in other familial cancer syndromes. Another 12 cases (2%) carried ultrarare variants that were predicted to be deleterious by three protein prediction programs; these most frequently involved ATM and BRCA2. CONCLUSIONS: A subset of patients with lung adenocarcinoma, at least 2.5% to 4.5%, carry germline variants that have been linked to cancer risk in Mendelian syndromes. The genes fall most frequently in DNA repair pathways. Our data indicate that patients with lung adenocarcinoma, similar to other solid tumors, include a subset of patients with inherited susceptibility.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Parry EM, Gable DL, Stanley SE, et al. Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma. J Thorac Oncol. 2017. PMID: 28843361. doi:10.1016/j.jtho.2017.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。